The International Generic and Biosimilar medicines Association (IGBA) was founded to strengthen cooperation between associations representing manufacturers of generic and biosimilar medicines from around the world. The IGBA is at the forefront of preserving sustainable competition within our industry, by stimulating competitiveness and innovation in the pharmaceutical sector; thereby, ensuring millions of patients around the world have access to high quality, pro-competitive medicines. For more details, regarding IGBA and its member associations, see the IGBA website at: www.igbamedicines.org.
| Website | https://www.igbamedicines.org/ |
| Revenue | $5 million |
| Employees | 11 (6 on RocketReach) |
| Founded | 2015 |
| Address | 11 C/o Dyn Sa Rue De Cornavin, Geneva, Geneva 1201, CH |
| Phone | +32 2 736 84 11 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Generic Medicines, Biosimilar Medicines, Pharmaceutical Association, Global Pharmaceuticals, Drug Manufacturing, Healthcare Association, International Cooperation, Biosimilars, Generics, Pharmaceutical Industry, Drug Development, Global Health, Health Policy, Medicine Access, Drug Pricing, Healthcare Advocacy, Global Healthcare |
| Competitors | Google, Medscape, New England Medical Research, Cureus Journal of Medical Science, Epocrates Inc, DynaMed, Merck Manuals, ClinicalKey, Cochranelibrary, MedPage +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Igba employee's phone or email?
The Igba annual revenue was $5 million in 2026.
James Pfitzer is the Chair, International External Engagement Committee (IEEC) of Igba.
6 people are employed at Igba.
Igba is based in Geneva, Geneva.
The NAICS codes for Igba are [325, 3254, 32541, 32].
The SIC codes for Igba are [28, 283].